Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies-Reference-Cited by-同舟云学术

Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies

Published:2013-07 Issue:1 Volume:190 Page:199-207
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Gelbard Martin¹²,Goldstein Irwin³⁴,Hellstrom Wayne J.G.⁵,McMahon Chris G.⁶⁷,Smith Ted⁸,Tursi James⁸,Jones Nigel⁹,Kaufman Gregory J.⁸,Carson Culley C.¹⁰

Affiliation:

1. Urology Associates Medical Group, Burbank, California

2. Department of Urology, University of California-Los Angeles, Los Angeles, California

3. San Diego Sexual Medicine, San Diego, California

4. University of California-San Diego, San Diego, California

5. Department of Urology, Tulane University Health Sciences Center, New Orleans, Louisiana

6. University of Sydney, Sydney, New South Wales, Australia

7. Australian Centre for Sexual Health, St. Leonards, New South Wales, Australia

8. Auxilium Pharmaceuticals, Inc., Malvern, Pennsylvania

9. Auxilium Pharmaceuticals, Inc., Cardiff, United Kingdom

10. University of North Carolina, Chapel Hill, North Carolina

Publisher